Brister Mark Insider Trades

Insider Trading History

Track insider trading activity for Brister Mark. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Obalon Therapeutics
Obalon Therapeutics OBLN
Chief Technology Officer
Holding Value $336k 110,281 shares
Last Trade
Jan 24, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$207k 110,281 shares
$1.88
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Chief Technology Officer
Holding Value $39.7k 13,000 shares
Last Trade
Oct 25, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.8k 13,000 shares
$1.75
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Chief Technology Officer
Holding Value $119k 38,865 shares
Last Trade
Aug 06, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$28.4k 8,750 shares
$3.25
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Chief Technology Officer
Holding Value $107k 35,000 shares
Last Trade
Jul 23, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$336k 35,000 shares
$9.60
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Chief Technology Officer
Holding Value $305k 100,000 shares
Last Trade
Jan 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.3M 100,000 shares
$23.00
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Chief Technology Officer
Holding Value $1.03M 338,634 shares
Last Trade
Aug 23, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.85M 107,142 shares
$26.60
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Chief Technology Officer
Holding Value $1.03M 338,634 shares
Last Trade
Aug 23, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.85M 107,142 shares
$26.60
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Chief Technology Officer
Holding Value $508k 166,492 shares
Last Trade
Apr 30, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$101k 2,622 shares
$38.50
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Chief Technology Officer
Holding Value $508k 166,492 shares
Last Trade
Apr 30, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$101k 2,622 shares
$38.50
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Chief Technology Officer
Holding Value $198k 65,000 shares
Last Trade
Jan 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.65M 65,000 shares
$71.50
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Chief Technology Officer
Holding Value $500k 163,870 shares
Last Trade
Oct 31, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$157k 1,860 shares
$84.30
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
VP Of Research And Development
Holding Value $494k 162,010 shares
Last Trade
Apr 30, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165k 1,550 shares
$106.20
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
VP Of Research And Development
Holding Value $275k 90,000 shares
Last Trade
Nov 09, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.87M 90,000 shares
$87.40
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
VP Of Research And Development
Holding Value $489k 160,460 shares
Last Trade
Oct 05, 2016 Sale
No data
No data
$3.05
Dexcom
Dexcom DXCM
Vp, Advanced Development Team
Holding Value $3.09M 42,617 shares
Last Trade
Nov 02, 2007 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 50,000 shares
$2.24
$72.59
Dexcom
Dexcom DXCM
Vp, Advanced Development Teams
Holding Value $4.1M 56,518 shares
Last Trade
Mar 09, 2007 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$136k 75,000 shares
$1.81
$72.59
Dexcom
Dexcom DXCM
VP Advanced Development Teams
Holding Value $796k 10,967 shares
Last Trade
May 02, 2006 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$72.59
Dexcom
Dexcom DXCM
Vp, Advanced Development Teams
Holding Value $1.22M 16,777 shares
Last Trade
Dec 07, 2005 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$72.59
Dexcom
Dexcom DXCM
Vp, Advanced Development Teams
Holding Value $4.27M 58,856 shares
Last Trade
Apr 13, 2005 Sale
No data
No data
$72.59

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up